PRF Technologies (PRFX) Other Working Capital Changes (2020 - 2024)
PRF Technologies (PRFX) posted quarterly Other Working Capital Changes of -$854000.0 for Q2 2024, down 876.36% year-on-year from $110000.0 in Q3 2023, and down 200.23% on a QoQ basis from $852000.0 in Q1 2024.
PRF Technologies (PRFX) Other Working Capital Changes (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has reported Other Working Capital Changes for 5 consecutive years, with -$854000.0 the latest figure, recorded in Q2 2024.
- Quarterly Other Working Capital Changes fell 876.36% year-over-year to -$854000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$309000.0 (up 59.5% YoY) and the FY2025 annual result came in at $22000.0, up 101.37% from the prior year.
- Other Working Capital Changes declined to -$4000.0 in Q2 2024 per PRFX's latest filing, from -$3000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for PRFX reached as high as $2.7 million in Q4 2020 and fell as low as -$977000.0 in Q4 2022.
- A 5-year average of $103071.4 and a median of $90500.0 in 2021 frame the typical range for Other Working Capital Changes.
- The largest YoY upside for Other Working Capital Changes was 740.6% in 2024 against a maximum downside of 876.36% in 2024.
- Year by year, Other Working Capital Changes stood at -$9000.0 in 2023, then surged by 55.56% to -$4000.0 in 2024.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$4000.0, -$3000.0, and -$9000.0 for Q2 2024, Q1 2024, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -854,000.00 |
| Jun 30, 2024 | -854,000.00 |
| Jun 30, 2024 | -854,000.00 |
| Mar 31, 2024 | 852,000.00 |
| Mar 31, 2024 | 852,000.00 |
| Mar 31, 2024 | 852,000.00 |
| Dec 31, 2023 | -271,000.00 |
| Dec 31, 2023 | -271,000.00 |
| Dec 31, 2023 | -271,000.00 |
| Sep 30, 2023 | -36,000.00 |
| Sep 30, 2023 | -36,000.00 |
| Sep 30, 2023 | -36,000.00 |
| Jun 30, 2023 | 110,000.00 |
| Jun 30, 2023 | 110,000.00 |
| Jun 30, 2023 | 110,000.00 |
| Mar 31, 2023 | -133,000.00 |
| Mar 31, 2023 | -133,000.00 |
| Mar 31, 2023 | -133,000.00 |
| Dec 31, 2022 | -977,000.00 |
| Dec 31, 2022 | -977,000.00 |